Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ercp post hoc efficacy and cost-benefit analyses using prospective clinical trial data

American Journal of Gastroenterology

Volumn 108, Issue 3, 2013, Pages 410-415

  Elmunzer, B Joseph ^a   Higgins, Peter D R ^a   Saini, Sameer D ^a   Scheiman, James M ^a   Parker, Robert A ^b   Chak, Amitabh ^c   Romagnuolo, Joseph ^d   Mosler, Patrick ^e,f   Hayward, Rodney A ^a   Elta, Grace H ^a   Korsnes, Sheryl J ^a   Schmidt, Suzette E ^g   Sherman, Stuart ^g   Lehman, Glen A ^g   Fogel, Evan L ^g  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^f KANTONSSPITAL GRAUBÜNDEN   (Switzerland)

^g INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN;

ARTICLE; COMPARATIVE EFFECTIVENESS; COST BENEFIT ANALYSIS; COST CONTROL; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; PANCREAS STENT PLACEMENT; PANCREATITIS; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; STENT; UNITED STATES;

ADMINISTRATION, RECTAL; ADULT; AGED; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; INDOMETHACIN; MALE; MIDDLE AGED; PANCREATITIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; TREATMENT OUTCOME;

EID: 84875223835     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.442     Document Type: Article

References (25)

1. Petrov MS, Savides TJ. Systematic review of endoscopic ultrasonography versus endoscopic retrograde cholangiopancreatography for suspected choledocholithiasis. Br J Surg 2009; 96: 967-74.
2. Romagnuolo J, Bardou M, Rahme E et al. Magnetic resonance cholangiopancreatography: a meta-analysis of test performance in suspected biliary disease. Ann Intern Med 2003; 139: 547-57.
3. Mazen Jamal M, Yoon EJ, Saadi A et al. Trends in the utilization of endoscopic retrograde cholangiopancreatography in the United States. Am J Gastroenterol 2007; 102: 966-75.
4. Sherman S, Troiano FP, Hawes RH et al. Sphincter of Oddi manometry: Decreased risk of clinical pancreatitis with use of a modifi ed aspirating catheter. Gastrointest Endosc 1990; 36: 462-6.
5. Cennamo V, Fuccio L, Zagari RM et al. Can a wire-guided cannulation technique increase bile duct cannulation rate and prevent post-ERCP pancreatitis?: A meta-analysis of randomized controlled trials. Am J Gastroenterol 2009; 104: 2343-50.
6. Coté GA, Ansstas M, Pawa R et al. Diffi cult biliary cannulation: use of physiciancontrolled wire-guided cannulation over a pancreatic duct stent to reduce the rate of precut sphincterotomy (with video). Gastrointest Endosc 2010; 71: 275-9.
7. Freeman ML. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol 2007; 5: 1354-65.
8. Brackbill S, Young S, Schoenfeld P et al. A survey of physician practices on prophylactic pancreatic stents. Gastrointest Endosc 2006; 64: 45-52.
9. Choudhary A, Bechtold ML, Arif M et al. Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review. Gastrointest Endosc 2011; 73: 275-82.
10. Mazaki T, Masuda H, Takayama T. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy 2010; 42: 842-5.
11. Das A, Singh P, Sivak Jr MV et al. Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis. Gastrointest Endosc 2007; 65: 960-8.
12. Tarnasky PR, Palesch YY, Cunningham JT et al. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998; 115: 1518-24.
13. Fazel A, Quadri A, Catalano MF et al. Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study. Gastrointest Endosc 2003; 57: 291-4.
14. Zolotarevsky E, Fehmi SM, Anderson MA et al. Prophylactic 5-Fr pancreatic duct stents are superior to 3-Fr stents: a randomized controlled trial. Endoscopy 2011; 43: 325-30.
15. Freeman ML, Overby C, Qi D. Pancreatic stent insertion: consequences of failure and results of a modifi ed technique to maximize success. Gastro intest Endosc 2004; 5: 8-14.
16. Freeman ML. Role of pancreatic stents in prevention of post-ERCP pancreatitis. JOP 2004; 5: 322-7.
17. Elmunzer BJ, Scheiman JM, Lehman GA et al. US. Cooperative for Outcomes Research in Endoscopy (USCORE). A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med 2012; 366: 1414-22.
18. Cotton PB, Lehman G, Vennes J et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991; 37: 383-93.
19. Freeman ML, DiSario JA, Nelson DB et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 2001; 54: 425-34.
20. 2012 Medicare physician fee and hospital schedules for Michigan Loc 01. Centers for Medicare and Medicaid Services (http://www.cms.gov/ Medicare/Medicare.html); Accessed 15 June-2012.
21. National inpatient sample -Healthcare Cost and Utilization Project. Rockville,MD: Agency for Healthcare Research and Quality http://hcupnet. ahrq.gov; Accessed 17 June-2012.
22. Briggs AH, Claxton K, Sculpher MJ. Decision Modeling for Health Economic Evaluation. Oxford University Press: New York, NY, 2006.
23. Leuven E, Sianesi B. PSMATCH2: stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing. http://ideas.repec.org/c/boc/bocode/s432001. html Version 4.0.5 18apr2012-2012.
24. Freeman ML, Guda NM. Prevention of post-ERCP pancreatitis; a comprehensive review. Gastrointest Endosc 2004; 59: 845-64.
25. Cotton PB, Garrow DA, Gallagher J et al. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc 2009; 70: 80-8.